Amylin (AMLN) said to have rejected a $3.5B bid from Bristol-Myers (BMY) -Bloomberg
Tweet
Share
E-mailGet Alerts AMLN Hot Sheet
Join SI Premium – FREE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- Motorola Solutions buys counter-drone firm D-Fend for $1.5B
- Salem Media acquired by WaterStone at $1 per share, goes private
Create E-mail Alert Related Categories
Mergers and Acquisitions, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
